Erythropoietin receptor on cDC1s dictates immune tolerance
Nature • 12/10/2025 – 12/14/2025
Summary
Erythropoietin receptor on cDC1s plays a crucial role in dictating immune tolerance, according to a study published in Nature. This discovery may provide insights into the immune system's regulatory mechanisms, potentially offering new targets for therapies related to cancer and autoimmune diseases, as noted by Medical Xpress and Multiple Sclerosis News Today.
Advertisement
Lindy Score Breakdown (V4.2)
84d
Age
1
Sources
from cluster
1917
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1917/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1917/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 35
Source Reputation: Moderate trust (10/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 83 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Inside the rise of the ‘Make Europe Healthy Again’ movement
Stat News • Today
Opinion: CMS shouldn’t be paying for higher-than-necessary doses of cancer drugs
Stat News • Today
STAT+: Pharmalittle: We’re reading about an FDA-UniQure feud, Pfizer’s ‘problem’ with the agency, and more
Stat News • Today
STAT+: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says
Stat News • Today
STAT+: HHS starts phasing out Anthropic’s Claude
Stat News • Today
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News • Today
STAT+: How can HHS drive clinical AI adoption? The industry wish list is starting to take shape
Stat News • 2 days ago
STAT+: Trump’s drive to get Europe to pay more for drugs creates uncertainty for countries, patients
Stat News • 2 days ago
STAT+: A Merck cancer drug to watch
Stat News • 1 day ago
STAT+: Federal Medicaid audit finds massive overpayment for autism therapy in Colorado
Stat News • 2 days ago